• VIROLOGY TESTING IS TAKING A BIG LEAP FORWARD

    VIROLOGY TESTING IS TAKING A BIG LEAP FORWARD

    Introducing the Aptima Virology Portfolio on the Panther® system. Powerful assay performance for HIV-1, HCV and HBV, with the agility to deliver results for all 3 assays on a single instrument, and even in a single run.

    Introducing the Aptima Virology Portfolio on the Panther® system. Powerful assay performance for HIV-1, HCV and HBV, with the agility to deliver results for all 3 assays on a single instrument, and even in a single run.

  • PANTHER NOW TARGETS HBV

    PANTHER NOW TARGETS HBV

    Introducing the Aptima HBV Quant assay on the Panther® system: The only CE-IVD certified assay for HBV viral load with dual targets for exceptional performance across a wide linear range and all major HBV genotypes.

    Introducing the Aptima HBV Quant assay on the Panther® system: The only CE-IVD certified assay for HBV viral load with dual targets for exceptional performance across a wide linear range and all major HBV genotypes.

  • EXPAND THE HUNT FOR VIRAL LOAD

    EXPAND THE HUNT FOR VIRAL LOAD

    The Aptima HCV Quant Dx assay: CE-IVD certified for confirmation of active HCV infection and monitoring of HCV viral load
    on the fully automated Panther® system.

    The Aptima HCV Quant Dx assay: CE-IVD certified for confirmation of active HCV infection and monitoring of HCV viral load
    on the fully automated Panther® system.

  • PANTHER HAS NEW PREY

    PANTHER HAS NEW PREY

    The Aptima HIV-1 Quant Dx assay on the Panther® system.

    The Aptima HIV-1 Quant Dx assay on the fully automated Panther® system sets the standard in nucleic acid amplification testing (NAAT) for HIV-1 diagnosis and treatment monitoring.

  • SEE APTIMA AND PANTHER
    IN ACTION

    SEE APTIMA AND PANTHER IN ACTION

    Publications, posters, press releases and more.

    Browse publications, conference posters, press releases and more to learn about the Aptima nucleic acid amplification tests (NAATs).

1 of 6

THE NEW STANDARD IN HIV-1 MOLECULAR TESTING

HCV HAS NOWHERE
TO HIDE

DUAL-TARGET HBV TREATMENT MANAGEMENT

HOME

CONSOLIDATE. AUTOMATE. GROW.

The Panther system consolidates a broad assay menu on a single, fully automated platform so you can test HIV-1, HCV, HBV and sexually transmitted infections (STIs)—including chlamydia, gonorrhea, HPV and trichomoniasis—in parallel.

The Panther system workflow is flexible—with no batching requirements and continuous access to samples and reagents—so you can load, process and prioritize samples based on your lab's needs. See how the Panther system can streamline your lab.

Current Aptima assay targets:

  • HIV-1 Quant*
  • HCV Quant*
  • HBV Quant*
  • CT/NG
  • HPV
  • HPV GT
  • CT*
  • NG*
  • Trichomoniasis
  • M. gen

Aptima assay targets in development:

  • HSV 1 & 2
  • Candida
  • Bacterial vaginosis
 

*Not available for sale in the U.S.

See how Aptima HIV-1 Quant Dx assay works in HIV-1 detection & quantitation.
See how Hologic is bringing its legacy of innovation to today’s world of molecular diagnostic testing.
Learn how real-time TMA captures, detects and quantitates HIV-1 RNA
Learn how real-time TMA leads to highly sensitive, highly specific assay performance.